Ever Source Wealth Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Ever Source Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$98.98 - $115.74 $3,365 - $3,935	34 Added 3.44%	1,021 $118,000
Q2 2023 Aug 04, 2023	SELL	$96.34 - $112.38 $21,580 - $25,173	-224 Reduced 18.5%	987 $101,000
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $1,287 - $1,362	12 Added 1.0%	1,211 $132,000
Q4 2022 Feb 09, 2023	BUY	$62.39 - $113.8 $25,455 - $46,430	408 Added 51.58%	1,199 $136,000
Q3 2022 Nov 07, 2022	SELL	$58.92 - $84.67 $7,836 - $11,261	-133 Reduced 14.39%	791 $49,000
Q2 2022 Aug 01, 2022	BUY	$79.4 - $116.36 $3,573 - $5,236	45 Added 5.12%	924 $73,000
Q1 2022 May 25, 2022	BUY	$86.42 - $109.81 $23,679 - $30,087	274 Added 45.29%	879 $92,000
Q4 2021 Feb 07, 2022	BUY	$98.56 - $119.91 $59,628 - $72,545	605 New	605 $65,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.